Purpose of the company: The commercial distribution of medicines and pharmaceutical products within the meaning of the Medicines Act (AMG) to third parties, import, export, re-import, repackaging, re-labeling or labeling of finished medicinal products, as well as the conduction of clinical trials and the provision of services in the pharmaceutical sector both within and...
Adress: Marie-Curie-Str. 11 61381 Friedrichsdorf Deutschland
Local court: 61352 Bad Homburg v.d.H.
Register number: HRB7637
The average total assets of company axicorp GmbH over the last 5 years is 51.569.311,55 âŹ.
The company axicorp GmbH as of the reporting date 2022 a bank balance of approx. 94.076,18 âŹ. That is -99,54 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of axicorp GmbH is 37,90 % in the year 2022. In total, that ist 29.650.307,86 âŹ.
The average absolute change in liquidity of the company axicorp GmbH compared to the previous year amounts to -11.026,04 âŹ. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company axicorp GmbH amounts to -44.104,14 ⏠in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.